RXRX Today - Jul 10: Insider Selling Hits Stock

カートのアイテムが多すぎます

ご購入は五十タイトルがカートに入っている場合のみです。

カートに追加できませんでした。

しばらく経ってから再度お試しください。

ウィッシュリストに追加できませんでした。

しばらく経ってから再度お試しください。

ほしい物リストの削除に失敗しました。

しばらく経ってから再度お試しください。

ポッドキャストのフォローに失敗しました

ポッドキャストのフォロー解除に失敗しました

RXRX Today - Jul 10: Insider Selling Hits Stock

無料で聴く

ポッドキャストの詳細を見る

Hey there! It's Joey here, your friendly neighborhood investor. I’ve been in the game for a while, and today we're talking about Recursion Pharmaceuticals, or RXRX for short. Spoiler alert: it was a red day today. The stock got smoked, dropping about 7.6%. Ouch.

So, what went down? Well, the stock started off strong pre-market, even soaring at first after some positive Q4 news and the CEO hyping up that the company hit an “inflection point.” Sounds cool, right? But then, things took a turn. The energy fizzled out as news broke that one of the directors, Blake Borgeson, sold off a hefty chunk of his shares—40,000 to be exact. That’s about $158,500 worth. Yeah, that one stung for investors. When you see insiders selling, it kinda makes you wonder. Like, are they not feeling so hot about the future?

Now, why did this happen? The buzz was all about that initial good news, but then the sell-off from Borgeson threw a wet blanket over the excitement. Investors started hitting the sell button fast, probably feeling a bit uneasy about what this insider move meant for the company’s future. Plus, the volume was way below average for the day, which tells you that folks were either scared or just not buying what they were selling.

Looking ahead, keep in mind that Recursion’s been pushing hard in the AI space, so they might have some interesting updates coming. But with today’s action, it’s clear people are on edge.

So, that’s the scoop on RXRX. It’s a wild ride, as always! Remember, I’m just here to share what I see, not give advice on what you should do with your cash. Stay curious and keep it fun out there!

まだレビューはありません